OBWP
GWPH

O'Brien Wealth Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

O'Brien Wealth Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-98
Closed -$17K – 217
2018
Q3 		$17K Buy
+98
New +$14.1K 0.01% 110
2018
Q2 		– Sell
-75
Closed -$8K – 183
2018
Q1 		$8K Buy
+75
New +$9.43K 0.01% 126

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

O'Brien Wealth Partners's GWPH Position: Q4 2018 in Review

O'Brien Wealth Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 98 shares — an estimated $17K sold.

O'Brien Wealth Partners first reported a position in GWPH in Q1 2018 and held it in 2 quarters. The position peaked at $17K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • O'Brien Wealth Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • O'Brien Wealth Partners sold 98 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $17K.
  • O'Brien Wealth Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 2 quarters.
  • O'Brien Wealth Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $17K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on O'Brien Wealth Partners's 13F filing for Q4 2018, filed 17 Jan 2019.